DGKα has been shown to regulate both VEGF and HIF-1 signaling [3,8]—providing mechanisms to regulate angiogenesis—and DGKα targeting of the mesenchymal phenotype may also have an impact given that MES GBM is highly vascularized and linked to high expression of angiogenic drivers [39]. This evidence concerns the gene DGKA and glioblastoma.